Invex Therapeutics Limited (ASX:IXC) Reports December Quarter Activities
Invex Therapeutics Limited (ASX:IXC) reported significant advancements in Exenatide research and a solid financial position in its December quarterly activities update.
Invex Therapeutics Limited (ASX:IXC) reported significant advancements in Exenatide research and a solid financial position in its December quarterly activities update.
Compumedics Limited (ASX:CMP) announces a new five-year contract with Philips Australia, enhancing its leading Somfit sleep testing program.
Vinyl Group Ltd (ASX: VNL) successfully completed its retail entitlement offer, raising $7.65 million to support acquisitions and growth.
Global Health Limited (ASX: GLH) reports significant cash flow growth and revenue increases for December 2024 quarter amidst challenging market conditions.
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Wellnex Life (ASX:WNX) updates on Pain Away acquisition funding and future dual listing plans.
Liontown Resources (ASX:LTR) reports strong production and financial performance for the December quarter, achieving positive cash flow.
Hazer Group Limited reports significant operational milestones and financial strength in its Q4 2024 update.
BHP reports a significant operational performance increase with a 10% rise in copper production and strategic developments for future growth.
Alkane Resources Ltd announces significant gold intercepts at Tomingley, enhancing exploration potential.